ISSN: 1308-5727 | E-ISSN: 1308-5735
Volume : 7 Issue : 2 Year : 2024
Forms

Abstracting & Indexing
Turkish Society for Pediatric Endocrinology and Diabetes
Coexistence of Kabuki Syndrome and Autoimmune Thyroiditis [J Clin Res Pediatr Endocrinol]
J Clin Res Pediatr Endocrinol. 2015; 7(2): 83-83

Coexistence of Kabuki Syndrome and Autoimmune Thyroiditis

Fatih Gürbüz1, Özge Özalp Yüreğir2, Serdar Ceylaner3, Ali Kemal Topaloğlu4, Bilgin Yüksel4
1Ankara Pediatric Hematology And Oncology Research And Training Hospital, Clinic Of Pediatric Endocrinology, Ankara, Turkey
2Adana Numune Training And Research Hospital, Adana, Turkey
3Intergen Genetics Center, Clinic Of Medical Genetics, Ankara, Turkey
4Çukurova University Faculty Of Medicine, Department Of Pediatric Endocrinology, Adana, Turkey

Kabuki syndrome (KS) is a multiple congenital anomalies/intellectual disability syndrome characterized by developmental delay, specific facial features, skeletal and visceral abnormalities. This syndrome is caused by mutations in the MLL2 and KDM6A genes. The autoimmune abnormalities have been described in very rare patients with KS. Herein, we present a very rare condition, KS coexisting with autoimmune thyroiditis and vitiligo. A seven-year-seven-month-old girl presented with short stature. There was no consanguinity between her parents. She was born as a term neonate weighing 2100 gram as a twin baby with no perinatal complications. On physical examination, her typical facial features were large and low-set ears, broad and arched eyebrows, elongated palpebral fissures with eversion of the lateral third of the lower eyelid, high and narrow palate. Other phenotypic malformations were numerous vitiligo lesions of different size in the neck, brachydactyly, prominent fetal finger pads, and joint hyperlaxity. Her laboratory findings revealed autoimmune thyroiditis. Thyroid-stimulating hormone (TSH) was 242 mIU/L (reference range: 0.55-6.7) and free thyroxine (fT4) was 0.42 ng/dL (reference range: 0.91-1.92). Anti-microsomal antibody was 450.6 U/mL (reference range: 0-9) and anti-thyroglobulin antibody was 2766 U/mL (reference range: 0-4). Patient’s thyroid ultrasonography was consistent with thyroiditis with reduced parenchyma and rough pattern. Levothyroxine-replacement therapy (50 µg/day) induced euthyroid state (TSH: 3.65 mIU/L and fT4: 1.15 ng/dL). We detected a de novo heterozygous p.R2471* (c.7411C >T) mutation in the patient. No mutation was detected in the MLL2 gene in her parents and brother. To our knowledge, this mutation was not reported in KS patients to date.

Keywords: Kabuki syndrome, autoimmune thyroiditis, vitiligo, MLL2 gene, mutation

Fatih Gürbüz, Özge Özalp Yüreğir, Serdar Ceylaner, Ali Kemal Topaloğlu, Bilgin Yüksel. Coexistence of Kabuki Syndrome and Autoimmune Thyroiditis. J Clin Res Pediatr Endocrinol. 2015; 7(2): 83-83
Manuscript Language: English
LookUs & Online Makale